Cardiovascular Device Update articles from January 2004

Cardiovascular Device Update archives from January 2004

Interventional technologies in stroke, heart disease treatment.
January 1, 2004... ORLANDO, Florida -- Interventional therapies, and drug-eluting coronary stents in particular, have had a major impact on the management of cardiovascular disease over the past decade. In 2003, the number of patients treated with coronary stents...

Clinical validation of AEDs continues to drive growth of sector.
January 1, 2004... ORLANDO, Florida -- One of the real buzzes at November's annual scientific sessions of the American Heart Association (AHA; Dallas, Texas) was the continuing clinical validation of the role of public access defibrillation in reducing mortality....

P-selectin inhibitors tested on clot particles.(From the lab)
January 1, 2004... "For a medical disorder affecting more than a quarter-million Americans each year," said vascular surgeon Thomas Wakefield, "we researchers don't know much more today about what causes blood clots in veins than our predecessors did over 100...

NHS Care Records to bring UK 'revolution'.(Report from Europe)
January 1, 2004... A CDU Staff Report Describing the effort as "a revolution in health and care information," the UK government last month announced a program intended to result in every National Health Service (NHS) patient in England having an electronic...

Bio-Imaging Technologies (Newtown, Pennsylvania) has acquired the intellectual property of privately held CapMed (Wilmington, Delaware), including the Personal Health Record (PHR) software and the patent-pending Personal HealthKey technology.(Acquisitions)
January 1, 2004... * Bio-Imaging Technologies (Newtown, Pennsylvania) has acquired the intellectual property of privately held CapMed (Wilmington, Delaware), including the Personal Health Record (PHR) software and the patent-pending Personal HealthKey technology....

Edwards Lifesciences (Irvine, California) said during its 2003 Investor Conference in early December that it would take "aggressive steps" to improve its U.S. heart valve sales growth rate.(Acquisitions)
January 1, 2004... * Edwards Lifesciences (Irvine, California) said during its 2003 Investor Conference in early December that it would take "aggressive steps" to improve its U.S. heart valve sales growth rate. A few days later, it announced plans to buy...

Panel puts Taxus on track as 2nd U.S. DES.(Business Developments)
January 1, 2004... An FDA advisory panel gave its unanimous backing to the second in what is likely to be a lengthening line of premarket approval (PMAs) applications for drug-eluting stents (DES). The nod went to the Taxus paclitaxel-eluting coronary stent from...

Abbott Laboratories (Abbott Park, Illinois) unveiled a collaboration and license agreement with global pharmaceutical company Wyeth (Madison, New Jersey) to develop an automated blood test to monitor therapeutic levels of the anti-rejection drug Rapamune.(Agreements)
January 1, 2004... * Abbott Laboratories (Abbott Park, Illinois) unveiled a collaboration and license agreement with global pharmaceutical company Wyeth (Madison, New Jersey) to develop an automated blood test to monitor therapeutic levels of the anti-rejection...

Angiotech Pharmaceuticals (Vancouver, British Columbia) said its license agreement with C.R. Bard (Murray Hill, New Jersey) has been terminated by mutual agreement of the two companies.(Agreements)
January 1, 2004... * Angiotech Pharmaceuticals (Vancouver, British Columbia) said its license agreement with C.R, Bard (Murray Hill, New Jersey) has been terminated by mutual agreement of the two companies. The agreement, originally entered into in 1998, provided...

Boston Scientific (Natick; Massachusetts) said it is now the exclusive global distributor for the Polar-CathPeripheral Dilatation System, a balloon angioplasty device that combines dilatation with cryogenic therapy designed to treat atherosclerotic disease of the legs and other peripheral arteries.(Agreements)
January 1, 2004... * Boston Scientific (Natick; Massachusetts) said it is now the exclusive global distributor for the Polar-CathPeripheral Dilatation System, a balloon angioplasty device that combines dilatation with cryogenic therapy designed to treat...

HealtheTech (Golden, Colorado), a company that develops and markets hand-held medical devices and software for the measurement of resting metabolic rate and nutrition monitoring, has entered into a supply and services agreement with Virgin Active (Central Milton Keynes, UK) to offer metabolism measurements to clients in more than 50 fitness facilities in the United Kingdom, Italy and South Africa.(Agreements)
January 1, 2004... * HealtheTech (Golden, Colorado), a company that develops and markets hand-held medical devices and software for the measurement of resting metabolic rate and nutrition monitoring, has entered into a supply and services agreement with Virgin...

Patient Care Techonology Systems (PCTS; Aliso Viejo, California), a medical software company offering advanced clinical information systems for hospital emergency departments, and Global Care Quest (GQC; Los Angeles, California), an emerging provider of mobile healthcare solutions, signed a strategic agreement to co-market their systems to hospital emergency departments.(Agreements)
January 1, 2004... * Patient Care Techonology Systems (PCTS; Aliso Viejo, California), a medical software company offering advanced clinical information systems for hospital emergency departments, and Global Care Quest (GQC; Los Angeles, California), an emerging...

Wyndgate Technologies (El Dorado, California), a division of Global Med Technologies (Lakewood, Colorado), has signed an agreement for its Vein-to-Vein software, SafeTrace donor management and SafeTrace Tx advanced transfusion management, with City of Hope National Medical Center (Duarte, California).(Agreements)
January 1, 2004... * Wyndgate Technologies (El Dorado, California), a division of Global Med Technologies (Lakewood, Colorado), has signed an agreement for its Vein-to-Vein software, SafeTrace donor management and SafeTrace Tx advanced transfusion management,...

Vascular disease seen as rarely diagnosed.(Market Updates)
January 1, 2004... The American Vascular Association (AVA) reported recently that more than 10 million of the nation's vascular disease sufferers have not been diagnosed, signaling a need for increased public education on the issue. The results of the AVA's...

CardioGenesis.(Personnel File)
January 1, 2004... * CardioGenesis (Foothill Ranch, California) reported that Chairman and Chief Executive Officer Michael Quinn has resumed the position of president, replacing Darrell Eckstein, who left the company to pursue other interests. Christine Ocampo...

EP MedSystems.(Personnel File)
January 1, 2004... * Kristine Fuimaono has joined EP MedSystems (West Berlin, New Jersey) as director of marketing. She most recently held the position of global marketing director at Biosense Webster. EP MedSystems develops cardiac electrophysiology products...

LipoScience.(Personnel File)
January 1, 2004... * Richard Pinnola has been appointed chief operating officer of LipoScience (Raleigh, North Carolina). He previously served as vice president of marketing and commercial development at TriPath Imaging and marketing director with Becton...

Ventracor.(Personnel File)
January 1, 2004... * Ventracor (Sydney, Australia) reported the resignation of chief financial officer and company secretary David Smullen. Ventracor is the developer of the VentrAssist Left Ventricular Assist System (LVAS), a third-generation LVAS featuring only...

Device aids efficiency of damaged hearts.(Product Pipeline)
January 1, 2004... A Swiss firm has developed a new non-invasive, portable device that delivers, in a proprietary manner, low-voltage stimulation impulses to the patient's skeletal muscles through adhesive electrodes to improve the efficiency of even the most...